Gynaecomastia: Aetiology and treatment options

Prostate Cancer and Prostatic Diseases

Volumn 2, Issue 4, 1999, Pages 167-171

  Tyrrell, C J ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Gynaecomastia; Monotherapy; Nonsteroidal antiandrogen; Prostate cancer; Radiotherapy

Indexed keywords

ANABOLIC AGENT; ANTIANDROGEN; ANTIESTROGEN; BICALUTAMIDE; BLEOMYCIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYPROTERONE ACETATE; DACTINOMYCIN; DANAZOL; DIETHYLSTILBESTROL; DILTIAZEM; DOXORUBICIN; ESTRAMUSTINE PHOSPHATE; ESTROGEN; ETHINYLESTRADIOL; FLUTAMIDE; GROWTH HORMONE; KETOCONAZOLE; NIFEDIPINE; NILUTAMIDE; POLYESTRADIOL PHOSPHATE; PREDNISONE; PROCARBAZINE; SPIRONOLACTONE; TAMOXIFEN; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ANDROGEN BLOOD LEVEL; CANCER HORMONE THERAPY; ESTROGEN BLOOD LEVEL; GYNECOMASTIA; HUMAN; INCIDENCE; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0033369089     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500314     Document Type: Review

References (52)

1. Mahoney CP. Adolescent gynecomastia. Differential diagnosis and management. Pediatr Clin North Am 1990; 37: 1389-1404.
2. Wilson JD, Aiman J, MacDonald PC. The pathogenesis of gynecomastia. Adv Intern Med 1980; 25: 1-32.
3. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979; 48: 338-340.
4. Braunstein GD. Gynecomastia. N Engl J Med 1993; 328: 490-495.
5. Boccon-Gibod L. Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer? Eur Urol 1998; 33: 159-164.
6. Mathur R, Braunstein GD. Gynecomastia: pathomechanisms and treatment strategies. Horm Res 1997; 48: 95-102.
7. Neuman JF. Evaluation and treatment of gynecomastia. Am Fam Physician 1997; 55: 1835-1844.
8. Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy 1993; 13: 37-45.
9. Mahler C, Denis L. Clinical profile of a new non-steroidal antiandrogen. J Steroid Biochem Mol Biol 1990; 37: 921-924.
10. Nydick M, Bustos J, Dale JH, Rawson RW. Gynecomastia in adolescent boys. JAMA 1961; 178; 449-454.
11. Niewoehner CB, Nuttall FQ. Gynecomastia in a hospitalized male population. Am J Med 1984; 77: 633-638.
12. Garcí Rodriguez LA, Jick H. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. Br Med J 1994; 308: 503-506.
13. Alfthan O, Holsti LR. Prevention of gynecomastia by local roentgen irradiation in estrogen-treated prostatic carcinoma. Scand J Urol Nephrol 1969; 3: 183-187.
14. Robinson MR et al. The final analysis of the EORTC Genito-urinary Tract Cancer Co-operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate. Eur Urol 1995; 28: 273-283.
15. Waterfall NB, Glaser MG. A study of the effects of radiation on prevention of gynecomastia due to oestrogen therapy. Clin Oncol 1979; 5: 257-260.
16. Kaisary AV, Tyrrell CJ, Peeling WB, Griffiths K. Comparison of LHRH analogue (Zoladex with orchidectomy in patients with metastatic prostatic carcinoma. Br J Urol 1991; 67: 502-508.
17. Tyrrell CJ et al. A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group. J Urol 1991; 146: 1321-1326.
18. Kolvenbag GJCM, Blackledge GRP. Worldwide activity and safety of bicalutamide: a summary review. Urology 1996; 47 (Suppl 1A): S70-S79.
19. Vahlensieck W et al. Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate. Urol Res 1985; 13: 209-212.
20. Küss R et al. Estramustine phosphate in the treatment of advanced prostatic cancer. Br J Urol 1980; 52: 29-33.
21. Pavone-Macaluso M et al. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group. J Urol 1986; 136: 624-631.
22. Oosterlinck W et al. Tolerability and safety of flutamide in monotherapy, with orchidectomy or with LHRH-a in advanced prostate cancer patients. A Belgian multicenter study of 905 patients. Eur Urol 1996; 30: 458-463.
23. Iversen P et al. Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years. Urology 1998; 51: 389-396.
24. Decensi AU et al. Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. J Urol 1991; 146: 377-381.
25. Eberlein TJ. Gynecomastia. In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds). Breast Diseases. JB Lippincott Company: Philadelphia, 1991, pp 46-50.
26. Larsson L-G, Sundbom C-M. Roentgen irradiation of the male breast. Acta Radiol 1962; 58: 253-256.
27. Brown JS, Rubenfeld S. Irradiation in preventing gynecomastia induced by estrogens. Urology 1974; 3: 51-53.
28. Cook S, Rodriguez-Antunez A. Pre-estrogen irradiation of the breast to prevent gynecomastia. Am J Roentgenol Radium Ther Nucl Med 1973; 117: 662-663.
29. Fass D, Steinfeld A, Brown J, Tessler A. Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela. Int J Radiat Oncol Biol Phys 1986; 12: 407-408.
30. Gagnon JD, Moss WT, Stevens KR. Pre-estrogen breast irradiation for patients with carcinoma of the prostate: a critical review. J Urol 1979; 121: 182-184.
31. Gangai MP, Shown TE, Sieber PE, Moore CA. External irradiation: a successful modality in preventing hormonally induced gynecomastia. J Urol 1967; 97: 338-339.
32. Malis I, Cooper JF, Wolever THS. Breast radiation in patients with carcinoma of the prostate. J Urol 1969; 102: 336-337.
33. Srinivasan V, Miree J Jr, Lloyd FA. Bilateral mastectomy and irradiation in the prevention of estrogen induced gynecomastia. J Urol 1972; 107: 624-625.
34. Wolf H, Madsen PO, Vermund H. Prevention of estrogen-induced gynecomastia by external irradiation. J Urol 1969; 102: 607-609.
35. Alfthan O, Kettunen K. The effect of roentgen ray treatment of gynecomastia in patients with prostatic carcinoma treated with estrogenic hormones: a preliminary communication. J Urol 1965; 94: 604-606.
36. Chou JL et al. Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy. Int J Radiat Oncol Biol Phys 1988; 15: 749-751.
37. Courtiss EH. Gynecomastia: Analysis of 159 patients and current recommendations for treatment. Plast Reconstr Surg 1987; 79: 740-752.
38. Park AJ, Lamberty BG. Gynaecomastia; have Webster's lessons been ignored? J R Coll Surg Edinb 1998; 43: 89-92.
39. Dolsky RL. Gynecomastia. Treatment by liposuction subcutaneous mastectomy. Dermatol Clin 1990; 8: 469-478.
40. Morselli PG. 'Pull-through': a new technique for breast reduction in gynecomastia. Plast Reconstr Surg 1996; 97: 450-454.
41. Ohyama T, Takada A, Fujikawa M, Hosokawa K. Endoscope-assisted transaxillary removal of glandular tissue in gynecomastia. Ann Plast Surg 1998; 40: 62-64.
42. Kuhn J-M et al. Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone. Clin Endocrinol 1983; 19: C513-520.
43. Buckle R. Danazol therapy in gynaecomastia: recent experience and indications for therapy. Postgrad Med J 1979; 55(Suppl 5): S71-S78.
44. Jones DJ et al. A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. Ann R Coll Surg Engl 1990; 72: 296-298.
45. Alagaratnam TT. Idiopathic gynecomastia treated with tamoxifen: a preliminary report. Clin Ther 1987; 9: 483-487.
46. Parker LN, Gray DR, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: a double-blind, crossover study. Metabolism 1986; 35: 705-708.
47. McDermott MT, Hofeldt FD, Kidd GS. Tamoxifen therapy for painful idiopathic gynecomastia. South Med J 1990; 83: 1283-1285.
48. Staiman VR, Lowe FC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 1997; 50: 929-933.
49. Serels S, Melman A. Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation. J Urol 1998; 159: 1309.
50. Le Roith D, Sobel R, Click SM. The effect of clomiphene citrate on pubertal gynecomastia. Acta Endocrinol (Copenli) 1980; 95: 177-180.
51. Plourde PV, Kuhn HE, Santener SJ. Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies. Am J Dis Child 1983; 137: 1080-1082.
52. Stepanas AV, Burner RB, Harding PE, Wise PH. Clomiphene in the treatment of pubertal-adolescent gynecomastia: a preliminary report. J Pediatr 1977; 90: 651-653.